Biologicals in IgE-mediated food allergy

Abstract

Purpose of reviewA better understanding of the most recent scientific literature in the use of biological therapy in the treatment of patients with IgE-mediated food allergy. Recent findingsA systematic review and meta-analysis demonstrated safety and effectiveness of omalizumab in the treatment of food allergy. The findings support the potential use of omalizumab as a monotherapy or as an adjunct to oral immunotherapy in IgE-mediated cow's milk allergy. The potential use of other biologics in the management of food allergy is subject of speculation. SummaryDifferent biological therapies are under evaluation for food allergic patients. The advance in literature will guide for a personalized treatment in the near future. However, additional research is needed to better understand the best candidate for each treatment, the optimal dose and timing.